In our study, increased protein expression of TRPV1 and TRPA1 in the U group could be reversed by treatment with LBP or CAP, indicating that LBP or CAP may relieve pain via inhibiting protein expression of TRPV1 and TRPA1. The gene discussed is TRPV1; the disease is Low back pain.